![Rainer Kramer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rainer Kramer
Corporate Officer/Principal bij
IMMATICS N.V.
Vermogen: - $ op 31-08-2026
Profiel
Dr. Rainer Kramer is a Chief Business Officer at Immatics Biotechnologies GmbH and a Chief Business Officer at Immatics NV.
He is on the Board of Directors at iOmx Therapeutics AG and Immatics US, Inc. Dr. Kramer was previously employed as a Chief Business Officer by Signature Diagnostics AG, a Vice President-Business Development by Jerini AG, a Head-Business Development by MorphoSys AG, and a Principal by Amgen, Inc. He received his undergraduate degree from the University of Regensburg and a doctorate degree from Max Planck Institute of Neurobiology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18-03-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Rainer Kramer
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMATICS N.V. | Corporate Officer/Principal | 01-01-2012 |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Corporate Officer/Principal | 01-04-2012 |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Directeur/Bestuurslid | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Directeur/Bestuurslid | 20-07-2022 |
Eerdere bekende functies van Rainer Kramer
| Bedrijven | Functie | Einde |
|---|---|---|
Signature Diagnostics AG
 Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Operates as a molecular diagnostics company | Corporate Officer/Principal | 01-05-2012 |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Corporate Officer/Principal | 01-08-2009 |
| MORPHOSYS AG | Corporate Officer/Principal | 01-01-2003 |
| AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van Rainer Kramer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Signature Diagnostics AG
Signature Diagnostics AG Pharmaceuticals: MajorHealth Technology Operates as a molecular diagnostics company | Health Technology |
Max Planck Institute of Neurobiology
 Max Planck Institute of Neurobiology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Develops adoptive cell therapies for treatment of cancer | Health Technology |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology Develops immunotherapy treatments for cancer patients | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
